VoxNeuro closes $4 Million to Help Diagnose Concussions and Alzheimer’s Disease

Cognitive health assessments are something that a lot of people have experienced, whether a professional athlete or weekend warrior who has suffered a potential brain surgery, or an oler person showing signs of memory loss. These brief brain health assessments typically involve a medical professional verbally surveying a patient, asking them to draw a shape or a clock, observing their behaviour, and reaching a determination. As VoxNeuro co-founder and chief science officer John Connolly notes, it’s a “fundamentally subjective” test regularly dramatized in television programs and films.

Backed by over 30 years of peer-reviewed research, VoxNeuro hopes to provide an objective answer to that assessment using software and electroencephalogram (EEG) electrodes.

Armed with $4 million CAD in fresh funding, the addition of an experienced healthtech exec in Jason Flowerday at the helm, and new clinical studies in the works with Boston University and the Canadian Armed Forces (CAF), VoxNeuro has set its sights on commercializing its software and expanding it for use in more targeted applications for concussions and Alzheimer’s disease.

Read the entire article in BetaKit.

VoxNeuro is an OBIO® member.